Trial
NCT05984784
A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD)
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Inmagene LLC
Collaborators
—
Condition
Atopic Dermatitis
Intervention
Placebo
Why stopped
Cohort 1 was completed. Cohort 2 was cancelled because data from Cohort 1 provided sufficient information for further development decision. No safety concerns were noted.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-06